Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-05-24

FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' supplemental application for fluvoxamine maleate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvoxamine Maleate (Fluvoxamine maleate)

Snippet

SUPPL AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)